Recent Finacing
Recent Raise
Roxro Pharmaceuticals is a specialty pharma that acquires abandoned pain drug candidates and advances them through clinical development, including late-stage intranasal analgesic ROX‑888 for planned FDA filing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors